Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avalo Therapeutics Inc (AVTX)

Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avalo Therapeutics Inc 540 Gaither Road Suite 400 Rockville MD 20850 USA

www.avalotx.com P: 410-522-8707

Description:

Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa.

Key Statistics

Overview:

Market Capitalization, $K 11,292
Enterprise Value, $K 3,872
Shares Outstanding, K 1,034
Annual Sales, $ 1,920 K
Annual Net Income, $ -31,540 K
Last Quarter Sales, $ 570 K
Last Quarter Net Income, $ -8,170 K
EBIT, $ -23,440 K
EBITDA, $ -17,550 K
60-Month Beta 1.21
% of Insider Shareholders 0.20%
% of Institutional Shareholders 87.06%
Float, K 1,032
% Float 99.80%
Short Volume Ratio 0.39

Growth:

1-Year Return -98.50%
3-Year Return -99.86%
5-Year Return -99.92%
5-Year Revenue Growth -89.53%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -5.98 on 05/13/24
Next Earnings Date 05/16/24
Earnings Per Share ttm -369.05
EPS Growth vs. Prev Year 97.05%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-240 on 12/29/23

AVTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,439.87%
Return-on-Assets % -54.17%
Profit Margin % -1,642.71%
Debt/Equity 0.00
Price/Sales 5.97
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 9.13
Interest Coverage -8.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar